Here’s what the HHS Secretary has achieved during his first six months in office — and what it means for pharma.

OpenAI’s life sciences bid; Major pharma manufacturing plant faulted by FDA; GLP-1 drugs linked to lower cancer rates.

J&J to invest $2 billion in North Carolina manufacturing following latest tariffs announcement; Serena Williams is the face ...

The NIL program — short for name, image and likeness — is an extension of Dexcom’s Warriors program, a global community of over 25,000 everyday people and celebrities — including Lance Bass, Patti ...

Viking’s stock craters on disappointing weight loss drug data; HHS’ mRNA reasoning faces scientific pushback; ...

Just over a third (33.5%) of marketers believe they have a good work-life balance and almost a quarter (24%) are stressed all or most of the time. According to a survey conducted by Storyblok of 200 ...

Read your plan documents to confirm whether the treatment or service is covered. Pay attention to any exclusions or limitations. Deutscher’s plan documents say hearing tests are not covered. But even ...

Bristol Myers Squibb appointed Nathan Pennell, MD, PhD, FASCO, as SVP, worldwide head of medical affairs for hematology and oncology, effective August 18. Nucleus RadioPharma hired former Food and ...

UnitedHealth Group’s multibillion-dollar pharmacy benefit manager, Optum Rx, is suing five Kentucky counties in an attempt to force them out of national opioid litigation against the company.

Whistleblower claims Meta deliberately exaggerated the success of its Shops ads to mitigate revenue losses caused by Apple’s privacy restrictions on iOS tracking.

The first cohort of seniors to have contended — not always enthusiastically — with a digital society has reached the age when cognitive impairment becomes more common.

Novo issues global hiring freeze for non-critical jobs; RFK, Jr. feuds with American Academy of Pediatrics; Why direct-to-consumer sales are unlikely to significantly lower drug costs.